← Open Payments lookup

ELIZABETH EGGEBRECHT: Open Payments

NPI 1174038590 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,094 in 238 payments from 11 companies in 2025. Trend: 2023 $2,065 · 2024 $2,022 · 2025 $3,094

Food & beverage: $3,094
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.41$536
Teva Pharmaceuticals USA, Inc.69$498
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$462
Alkermes, Inc.28$438
Janssen Pharmaceuticals, Inc16$384
Otsuka America Pharmaceutical, Inc.21$330
E.R. Squibb & Sons, L.L.C.15$248
ABBVIE INC.17$142
Axsome Therapeutics, Inc.1$21
Vanda Pharmaceuticals Inc.1$19

Products named: INGREZZA, CAPLYTA, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR, COBENFY, UZEDY, ABILIFY MAINTENA.

Industry payments across SC — which companies pay providers there.